Search

Cristina Riggio,1,* Maria Pilar Calatayud,2,* Clare Hoskins,3 Josephine Pinkernelle,4 Beatriz Sanz,2 Teobaldo Enrique Torres,2,5 Manuel Ricardo Ibarra,2,5 Lijun Wang,3 Gerburg Keilhoff,4 Gerardo Fabian Goya,2,5 Vittoria Raffa,1,6 Alfred Cuschieri1,3 1Institute of Life Science, Scuola Superiore Sant’Anna, Piazza Martiri della Libertà, Pisa, Italy; 2Instituto de Nanociencia de Aragón, Universidad de Zaragoza. Mariano Esquillor, Zaragoza, Spain; 3IMSaT, Institute for Medical Science and Technology, University of Dundee, Dundee, Scotland; 4Otto-von-Guericke University, Institute of Biochemistry and Cell Biology, Magdeburg, Germany; 5Departamento de Física de la Materia Condensada, Facultad de Ciencias, Universidad de Zaragoza. Cerbuna 12, Zaragoza, Spain; 6Department of Biology, Università di Pisa, Pisa, Italy*These authors contributed equally to this workPurpose: It has been proposed in the literature that Fe3O4 magnetic nanoparticles (MNPs) could be exploited to enhance or accelerate nerve regeneration and to provide guidance for regenerating axons. MNPs could create mechanical tension that stimulates the growth and elongation of axons. Particles suitable for this purpose should possess (1) high saturation magnetization, (2) a negligible cytotoxic profile, and (3) a high capacity to magnetize mammalian cells. Unfortunately, the materials currently available on the market do not satisfy these criteria; therefore, this work attempts to overcome these deficiencies.Methods: Magnetite particles were synthesized by an oxidative hydrolysis method and characterized based on their external morphology and size distribution (high-resolution transmission electron microscopy [HR-TEM]) as well as their colloidal (Z potential) and magnetic properties (Superconducting QUantum Interference Devices [SQUID]). Cell viability was assessed via Trypan blue dye exclusion assay, cell doubling time, and MTT cell proliferation assay and reac

Cristina Riggio,1,* Maria Pilar Calatayud,2,* Clare Hoskins,3 Josephine Pinkernelle,4 Beatriz Sanz,2 Teobaldo Enrique Torres,2,5 Manuel Ricardo Ibarra,2,5 Lijun Wang,3 Gerburg Keilhoff,4 Gerardo Fabian Goya,2,5 Vittoria Raffa,1,6 Alfred Cuschieri1,3 1Institute of Life Science, Scuola Superiore Sant’Anna, Piazza Martiri della Libertà, Pisa, Italy; 2Instituto de Nanociencia de Aragón, Universidad de Zaragoza. Mariano Esquillor, Zaragoza, Spain; 3IMSaT, Institute for Medical Science and Technology, University of Dundee, Dundee, Scotland; 4Otto-von-Guericke University, Institute of Biochemistry and Cell Biology, Magdeburg, Germany; 5Departamento de Física de la Materia Condensada, Facultad de Ciencias, Universidad de Zaragoza. Cerbuna 12, Zaragoza, Spain; 6Department of Biology, Università di Pisa, Pisa, Italy*These authors contributed equally to this workPurpose: It has been proposed in the literature that Fe3O4 magnetic nanoparticles (MNPs) could be exploited to enhance or accelerate nerve regeneration and to provide guidance for regenerating axons. MNPs could create mechanical tension that stimulates the growth and elongation of axons. Particles suitable for this purpose should possess (1) high saturation magnetization, (2) a negligible cytotoxic profile, and (3) a high capacity to magnetize mammalian cells. Unfortunately, the materials currently available on the market do not satisfy these criteria; therefore, this work attempts to overcome these deficiencies.Methods: Magnetite particles were synthesized by an oxidative hydrolysis method and characterized based on their external morphology and size distribution (high-resolution transmission electron microscopy [HR-TEM]) as well as their colloidal (Z potential) and magnetic properties (Superconducting QUantum Interference Devices [SQUID]). Cell viability was assessed via Trypan blue dye exclusion assay, cell doubling time, and MTT cell proliferation assay and reac

Liuba Taccola1, Vittoria Raffa2, Cristina Riggio2, Orazio Vittorio1,2, Maria Carla Iorio3, Renato Vanacore3, Andrea Pietrabissa4,5, Alfred Cuschieri21Department of Oncology, Transplantation and Advanced Technologies in Medicine, University of Pisa, Pisa; 2Medical Science Laboratory, Scuola Superiore Sant'Anna, Pisa; 3Laboratory of Immunogenetics, Immunohematology, Azienda Ospedaliera Universitaria Pisana, Pisa; 4Department of Surgical Science, Reanimation and Transplantation, University of Pavia, Pavia; 5Fondazione Policlinico San Matteo, Pavia, ItalyBackground: It has recently been demonstrated that zinc oxide nanoparticles (ZnO NPs) induce death of cancerous cells whilst having no cytotoxic effect on normal cells. However, there are several issues which need to be resolved before translation of zinc oxide nanoparticles into medical use, including lack of suitable biocompatible dispersion protocols and a better understanding being needed of the mechanism of their selective cytotoxic action. Methods: Nanoparticle dose affecting cell viability was evaluated in a model of proliferating cells both experimentally and mathematically. The key issue of selective toxicity of ZnO NPs toward proliferating cells was addressed by experiments using a biological model of noncancerous cells, ie, mesenchymal stem cells before and after cell differentiation to the osteogenic lineage.Results: In this paper, we report a biocompatible protocol for preparation of stable aqueous solutions of monodispersed zinc oxide nanoparticles. We found that the threshold of intracellular ZnO NP concentration required to induce cell death in proliferating cells is 0.4 ± 0.02 mM. Finally, flow cytometry analysis revealed that the threshold dose of zinc oxide nanoparticles was lethal to proliferating pluripotent mesenchymal stem cells but exhibited negligible cytotoxic effects to osteogenically differentiated mesenchymal stem cells.Conclusion: Results confirm the ZnO NP selective cyto

Liuba Taccola1, Vittoria Raffa2, Cristina Riggio2, Orazio Vittorio1,2, Maria Carla Iorio3, Renato Vanacore3, Andrea Pietrabissa4,5, Alfred Cuschieri21Department of Oncology, Transplantation and Advanced Technologies in Medicine, University of Pisa, Pisa; 2Medical Science Laboratory, Scuola Superiore Sant'Anna, Pisa; 3Laboratory of Immunogenetics, Immunohematology, Azienda Ospedaliera Universitaria Pisana, Pisa; 4Department of Surgical Science, Reanimation and Transplantation, University of Pavia, Pavia; 5Fondazione Policlinico San Matteo, Pavia, ItalyBackground: It has recently been demonstrated that zinc oxide nanoparticles (ZnO NPs) induce death of cancerous cells whilst having no cytotoxic effect on normal cells. However, there are several issues which need to be resolved before translation of zinc oxide nanoparticles into medical use, including lack of suitable biocompatible dispersion protocols and a better understanding being needed of the mechanism of their selective cytotoxic action. Methods: Nanoparticle dose affecting cell viability was evaluated in a model of proliferating cells both experimentally and mathematically. The key issue of selective toxicity of ZnO NPs toward proliferating cells was addressed by experiments using a biological model of noncancerous cells, ie, mesenchymal stem cells before and after cell differentiation to the osteogenic lineage.Results: In this paper, we report a biocompatible protocol for preparation of stable aqueous solutions of monodispersed zinc oxide nanoparticles. We found that the threshold of intracellular ZnO NP concentration required to induce cell death in proliferating cells is 0.4 ± 0.02 mM. Finally, flow cytometry analysis revealed that the threshold dose of zinc oxide nanoparticles was lethal to proliferating pluripotent mesenchymal stem cells but exhibited negligible cytotoxic effects to osteogenically differentiated mesenchymal stem cells.Conclusion: Results confirm the ZnO NP selective cyto